From August 21, 2023 to November 24, 2023, the company has repurchased 618,077 shares, representing 0.15% for CNY 20.01 million. With this, the company has completed the repurchase of 618,077 shares, representing 0.15% for CNY 20.01 million under the buyback announced on August 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.37 CNY | +1.08% | -2.74% | -30.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.14% | 1.21B | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- 688105 Stock
- News Nanjing Vazyme Biotech Co.,Ltd
- Tranche Update on Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback Plan announced on August 22, 2023.